1,880
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Evolving Consensus Experience of the IUSG-IOIS-FOIS with Uveitis in the Time of COVID-19 Infection

, MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, PhDORCID Icon, , MD, PhD, MPH & , MD, PhDORCID Icon show all
Pages 709-713 | Received 05 Jun 2020, Accepted 05 Jun 2020, Published online: 28 Jul 2020

References

  • Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020
  • Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet. 2020;395(10223):473–5
  • Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–407
  • Leonardi A, Rosani U, Brun P. Ocular surface expression of SARS-CoV-2 receptors. Ocul Immunol Inflamm. 2020. In press.
  • Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–51.
  • Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003 Nov 27;426(6965):450–4
  • https://jamanetwork.com/journals/jama/articlepdf/2763803/jama_patel_2020_vp_200063.pdf
  • Ferguson NM, Laydon D, Nedjati-Gilani G, Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College; 2020. DOI:10.25561/77482
  • D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020. DOI: 10.1002/lt.25756
  • Norsa L, Indriolo A, Sansotta N, Cosimo P, Greco S, D’Antiga L. Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy. Gastroenterol. 2020. DOI: 10.1053/j.gastro.2020.03.062
  • Bhoori S, Rossi RE, Citterio D, Mazzaferro V. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol Hepatol. 2020. DOI: 10.1016/S2468-1253(20)30116-3
  • Zhou Y et al (2020) Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID 19 patients. National Science Review. National Science Review, nwaa041, Available at: https://doi.org/10.1093/nsr/nwaa041 ( accessed 20. 3.2020)
  • Mehta P et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. Available at: DOI: https://doi.org/10.1016/S0140-6736(20)306280 ( accessed 20. 3.2020)
  • Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in Humans and animals. Ocul. Imm Infl https://doi.org/10.1080/09273948.2020.1738501
  • Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, Qin Y, Xiao K, Zhang H, Sun X. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020 May 18:10.1111/aos.14472. doi: 10.1111/aos.14472.
  • Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 DOI: 10.1001/jamaophthalmol.2020.1291
  • Abrishami M, Tohidinezhad F, Daneshvar R, Omidtabrizi A, Amini M, Sedaghat A, Amini S, Reihani H, Abolghasem A, Seddigh-Shamsi M, Tayyebi M, Naderi H, Bojdi A, Khodashahi R, Eslami S. Ocular manifestations of hospitalized patients with COVID-19 in northeast of Iran. Ocul Immunol Inflamm. 2020. In press.
  • Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92(6):589–594. doi: 10.1002/jmv.25725. Epub 2020 Mar 12.
  • Atum M, Box AAE, Cakir B, Karabay O, Koroglu M, Ogutlu A, Alagoz G. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocul Immunol Inflamm, In Press.
  • Liu Z, Sun CB. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract. J Med Virol. 2020 DOI:10.1002/jmv.25859
  • Sun CB, Wang YY, Liu GH, Liu Z. Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know. Front Public Health. 2020;8:155. DOI: 10.3389/fpubh.2020.00155
  • Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, Lye DC, Agrawal R. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020 Mar 24: S0161-6420(20)30311-0. doi: 10.1016/j.ophtha.2020.03.026
  • Wen DHC, Low R, Tong L, Gupta V, Aravamudan VM, Agrawal. COVID-19 and the ocular surface: A review of transmission and manifestations. Ocul Immunol Inflamm. 2020 Jun 16;1–9. doi: 10.1080/09273948.2020.1772313.
  • Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, Smith JR, de Smet MD, Biswas J. COVID-19: Limiting the Risks for Eye Care Professionals. Ocul Immunol Inflamm. 2020 Apr 20:1–7. doi: 10.1080/09273948.2020.1755442. Online ahead of print.
  • Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. 2020:100735.
  • Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. The Lancet. 2020. DOI:10.1016/s0140-6736(20)31014-x
  • Wang Y, Detrick B, Yu ZX, Zhang J, Chesky L, Hooks JJ. The role of apoptosis within the retina of coronavirus-infected mice. Invest Ophthalmol Vis Sci. 2000; 41(10):3011–3018.
  • Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020 Apr 2;28(3):391–395.
  • Casagrande M, Fitzek A, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased CIOVID-19 patients. Ocul. Immunol inflamm. DOI: 10.1080/09273948.2020.1770301
  • Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 Mar 3. pii:/j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml. doi:10.1515/cclm-2020-0198. [ Epub ahead of print] PubMed PMID: 32119647.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.